About nanoappsmedical

NanoApps Medical - Official website

Exotic magnetic states on the nanoscale

An international research team, led by scientists from the EMPA (Zurich) and the International Iberian Nanotechnology Laboratory, which has researchers from the UPV/EHU, has succeeded in building chains of quantum magnets made of nanographene that capture the essence of one of the core models of quantum magnetism. The team's results (Nature, "Observation of fractional edge excitations in [...]

By |2021-11-08T11:57:18+00:00November 8th, 2021|Categories: News|0 Comments

Scanning a single protein, one amino acid at a time

Using nanopore DNA sequencing technology, researchers from TU Delft and the University of Illinois have managed to scan a single protein: by slowly moving a linearized protein through a tiny nanopore, one amino acid at the time, the researchers were able to read off electric currents that relate to the information content of the [...]

By |2021-11-08T11:18:44+00:00November 8th, 2021|Categories: News|0 Comments

Using DNA Nanolevers to Measure Virus and Peptide Interactions

The bonding interaction amongst Influenza A and the peptide "PeB," which selectively binds the viral surface protein hemagglutinin, has been investigated using electrically controlled deoxyribonuclic acid (DNA) nanolevers in the journal Advanced Materials. PeB is conjugated to DNA strands that are bonded to complementary anchors and fixed on the electrode surface of a "switchSENSE" biochip. [...]

By |2021-11-08T11:06:04+00:00November 8th, 2021|Categories: News|0 Comments

The Future of SARS-CoV-2 Vaccination — Lessons from Influenza

After a period of falling Covid-19 illness rates, the recent spread of the delta variant of SARS-CoV-2 was a major disappointment and necessitated a reexamination of some previous assumptions. This reconsideration may, at least in part, be a correction to overly optimistic views of what highly effective SARS-CoV-2 vaccines could accomplish. Some observers had [...]

By |2021-11-07T12:29:12+00:00November 7th, 2021|Categories: News|0 Comments

Pfizer says its new COVID pill cuts risk of hospitalization and death by almost 90%

Drug giant announced results on Friday Study on 775 COVID patients found pill reduced hospitalization and death rates by 89 per cent compared to patients giving a dummy pill Results of independent study were so impressive Pfizer halted it early to seek approval for its usage It wants the Food and Drug Administration to authorize [...]

By |2021-11-05T12:59:24+00:00November 5th, 2021|Categories: News|0 Comments

Britain approves Merck’s COVID-19 pill in world first

UK approval for molnupiravir comes ahead of U.S. decision UK and NHS to confirm deployment plans in due course UK secured just under half a million courses last month Drug will be given to higher risk patients Approval comes as UK struggles to tame infections Nov 4 (Reuters) - Britain on Thursday became the [...]

By |2021-11-05T11:09:59+00:00November 5th, 2021|Categories: News|0 Comments

Nanotechnology is the medicine of the future

Nanotechnology represents the future of personalised medicine, especially in treating diseases like cancer, says a top Swiss researcher in the field. What can the technology do, and how close does it come to science fiction scenarios? For some, the term “nano” conjures strange scenarios out of science fiction. But nanoscience simply refers to a [...]

By |2021-11-04T15:26:14+00:00November 4th, 2021|Categories: News|0 Comments

Covid-19 virus does not infect human brain cells, study suggests

Exclusive: study raises hopes that Covid-related damage to sense of smell may be more superficial than previously feared. The virus that causes Covid-19 does not infect human brain cells, according to a study published in the journal Cell. The findings will raise hopes that the damage caused by Sars-CoV-2 might be more superficial and reversible than [...]

By |2021-11-04T12:05:15+00:00November 4th, 2021|Categories: News|0 Comments

In COVID-19 vaccinated people, those with prior infection likely to have more antibodies

In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable—that is, remain higher over an extended period of time—in people who were infected by the virus and then received protection from two doses [...]

By |2021-11-02T12:41:45+00:00November 2nd, 2021|Categories: News|0 Comments

Immunocompromised may need a fourth Covid-19 shot, CDC says

People with certain health conditions that make them moderately or severely immunocompromised may get a fourth mRNA Covid-19 shot, according to updated guidelines from the US Centers for Disease Control and Prevention. The CDC authorized a third dose for certain immunocompromised people 18 and older in August. It said a third dose, rather than a booster -- [...]

By |2021-11-01T12:39:35+00:00November 1st, 2021|Categories: News|0 Comments
Go to Top